Knowledge of pharmacodynamic and pharmacokinetic parameters is a critical component for characterizing active substances on a test system. We perform primary screening of compounds for pharmacological efficacy to help you select the right candidates for development.
Whether you need to evaluate how a test system affects your drug (PK) or how your drug affects a test system (PD), we have the ability and experience to conduct these studies in rodent and non-rodent species. This allows you to choose from a large selection of species to evaluate the pharmacokinetics of your test article.
Designated vivarium space for quick study starts, along with summary protocol/report formats, ensure you receive quality data quickly in order to set doses for safety studies.
- Small Molecules
- Large Molecules
- Gene and Stem Cell Therapies
- Nucleic Acid Therapeutics
- Genome Editing Technologies
Our deep expertise and capabilities in a broad range of therapeutic areas encompasses preclinical and early clinical studies for both small molecules and biologics. We can manage your entire program, as well as provide comprehensive support research services and bioanalytical expertise.
Please see Therapeutic Areas for a fuller discussion of our capabilities and expertise.